Objective: To investigate the comprehensiveness, quality, and reliability of YouTube videos that target teaching patients gonadotropin self-injections.
Study Design: Videos demonstrating gonadotropin self-injections were searched using the keywords "Gonal-f injection," "Puregon injection," "Menapur injection," "Merional injection," "Fostimon injection," and "Menagon injection," on December 20th, 2020. The videos were divided into two categories as including "useful information" and "misleading information" by two physicians. A 5-point global quality scale (GQS) and 5-point modified DISCERN scale were used for the assessments of quality and reliability, respectively.
Results: Among 110 videos, 90 (81.8%) were found to include useful information and 20 (18.2%) were found to give misleading information. The kappa statistic for inter-observer agreement was 0.817 (p < 0.001). Useful videos were the most comprehensive and had the highest reliability and quality scores. We found that all videos uploaded by universities or professional organizations included useful information. However, there was no significant difference between useful and misleading videos regarding audience interaction analysis parameters (p > 0.05). On the other hand, mean reliability, GQS, and comprehensiveness scores were higher in the useful information group than in the other group. As the subgroup analysis was performed by source, patient opinion videos had lower reliability, comprehensiveness, and GQS scores than videos created by other sources (p < 0.001).
Conclusion: Our analysis revealed that there were a significant number of English-language YouTube videos, with high quality, rich content, and reliability that could be sources of information on the accurate technique of gonadotropin self-injections. However, some misleading information videos may lead to negative outcomes. Therefore, physicians should ensure that online sources are comprehensive and reliable for the use of their patients with infertility. Also, YouTube health videos should be checked for both reliability and ethical standards.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/j.ejogrb.2021.07.015 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
YouTube as a source of information on gonadotropin self-injections.
Eur J Obstet Gynecol Reprod Biol
September 2021
Selçuk University Faculty of Medicine, Department of Obstetrics and Gynecology, Konya, Turkey.
Objective: To investigate the comprehensiveness, quality, and reliability of YouTube videos that target teaching patients gonadotropin self-injections.
Study Design: Videos demonstrating gonadotropin self-injections were searched using the keywords "Gonal-f injection," "Puregon injection," "Menapur injection," "Merional injection," "Fostimon injection," and "Menagon injection," on December 20th, 2020. The videos were divided into two categories as including "useful information" and "misleading information" by two physicians.
Patient perceptions and understanding of treatment instructions for ovarian stimulation during infertility treatment.
Reprod Biomed Soc Online
December 2019
Affaires Médicales MSD, Courbevoie, France.
Article Synopsis
- * Before treatment, patients rated their understanding of instructions and information as high, but a significant number had gaps in knowledge, particularly regarding medication dosing and anxiety about self-administering injections.
- * Despite patients reporting lower compliance (27%) than physicians perceived (94.3%), the findings suggest that miscommunication and misunderstanding in treatment protocols may still be common, highlighting the need for improved communication strategies.
Purpose: To evaluate the efficacy and safety of self-injections of the prefilled recombinant human chorionic gonadotropin (r-hCG) in a syringe in assisted reproductive technology (ART) treatment for the maturation trigger (MT), as compared to self-injections of conventional hCG and intranasal administration of gonadotropin-releasing hormone agonist (GnRH-a).
Methods: Between January and April, 2017, 396 patients who underwent oocyte retrieval were recruited. Of these, 396 patients were classified into three groups, according to the types of MT: (1) the urinary human chorionic gonadotropin (u-hCG) group that consisted of patients who had a self-injection of u-hCG (n = 127); (2) the GnRH-a group that received nasal administration of GnRH-a (n = 159); and (3) the r-hCG group that had a self-injection of r-hCG (n = 110).
The French study VISION is a multicentric, prospective and retrospective study, designed first to evaluate patients' quality of life during ovarian stimulation for ovulation induction, intrauterine insemination (IUI) or IVF, and secondly to analyse current medical practice in France. Answers were directly entered on a pocket PC. The study was conducted from January to August 2004 and 186 practitioners filled in a total of 1476 questionnaires.
View Article and Find Full Text PDF[Acceptability and value of autoinjection of gonadotropins for ovarian stimulation in intrauterine insemination].
Gynecol Obstet Fertil
October 2001
Service de gynécologie obstétrique III, clinique universitaire Baudelocque, hôpital Cochin, 123, boulevard de Port-Royal, 75014 Paris, France.
Objectives: To evaluate the acceptability, the personal and economic benefit of subcutaneous self-injections of recombinant FSH within mono-ovulating stimulation for Intra Uterine Insemination (IUI).
Patients And Methods: Women aged < 42 years' old, enrolled for a series of three IIU associated with ovarian stimulation with FSH. All had an infertility > 2 years, at least one patent fallopian tube, and normal FSH and estradiol levels at day three of the cycle.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!